Call for Britain to over-ride patents on Roche cancer drug

LONDON, Oct 1 (Reuters) - A group of patients and campaigners has called on Britain's health minister to over-ride patents protecting Roche's expensive breast cancer drug Kadcyla to allow for the import or manufacture of cut-price copies.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.